T. Rowe Price Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-170,569
| Closed | -$682K | – | 2596 |
|
|
2019
Q4 | $682K | Buy |
170,569
+115,834
| +212% | +$463K | ﹤0.01% | 2044 |
|
|
2019
Q3 | $268K | Sell |
54,735
-137,721
| -72% | -$674K | ﹤0.01% | 2313 |
|
|
2019
Q2 | $1.17M | Buy |
192,456
+9,800
| +5% | +$59.7K | ﹤0.01% | 1778 |
|
|
2019
Q1 | $1.06M | Buy |
182,656
+2,000
| +1% | +$11.6K | ﹤0.01% | 1813 |
|
|
2018
Q4 | $2.43M | Buy |
180,656
+598
| +0.3% | +$8.05K | ﹤0.01% | 1513 |
|
|
2018
Q3 | $3.5M | Sell |
180,058
-214,824
| -54% | -$4.17M | ﹤0.01% | 1500 |
|
|
2018
Q2 | $10.1M | Buy |
394,882
+225,569
| +133% | +$5.77M | ﹤0.01% | 1341 |
|
|
2018
Q1 | $3.41M | Buy |
169,313
+6,525
| +4% | +$131K | ﹤0.01% | 1470 |
|
|
2017
Q4 | $3.27M | Sell |
162,788
-5,350
| -3% | -$107K | ﹤0.01% | 1468 |
|
|
2017
Q3 | $3.48M | Buy |
168,138
+20,200
| +14% | +$418K | ﹤0.01% | 1469 |
|
|
2017
Q2 | $2.19M | Sell |
147,938
-1,262,022
| -90% | -$18.7M | ﹤0.01% | 1536 |
|
|
2017
Q1 | $22.5M | Sell |
1,409,960
-972,959
| -41% | -$15.5M | ﹤0.01% | 1112 |
|
|
2016
Q4 | $30M | Sell |
2,382,919
-1,934,731
| -45% | -$24.4M | 0.01% | 990 |
|
|
2016
Q3 | $121M | Sell |
4,317,650
-1,256,433
| -23% | -$35.2M | 0.02% | 531 |
|
|
2016
Q2 | $195M | Sell |
5,574,083
-48,851
| -0.9% | -$1.71M | 0.04% | 416 |
|
|
2016
Q1 | $154M | Buy |
5,622,934
+446,332
| +9% | +$12.2M | 0.03% | 457 |
|
|
2015
Q4 | $177M | Buy |
5,176,602
+746,569
| +17% | +$25.5M | 0.04% | 430 |
|
|
2015
Q3 | $127M | Sell |
4,430,033
-108,268
| -2% | -$3.11M | 0.03% | 514 |
|
|
2015
Q2 | $203M | Sell |
4,538,301
-323,507
| -7% | -$14.5M | 0.04% | 443 |
|
|
2015
Q1 | $163M | Sell |
4,861,808
-93,870
| -2% | -$3.15M | 0.03% | 483 |
|
|
2014
Q4 | $132M | Buy |
+4,955,678
| New | +$132M | 0.03% | 537 |
|